Immatics (IMTX) Other Non-Current Assets (2019 - 2025)
Immatics (IMTX) reported Other Non-Current Assets of $2.2 million for Q4 2025, up 61.22% on a YoY basis from $1.3 million in Q4 2024, and up 124.64% sequentially from $958625.2 in Q3 2025.
Immatics (IMTX) Other Non-Current Assets (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Other Non-Current Assets data on file, last reported at $2.2 million in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets rose 61.22% year-over-year to $2.2 million; the trailing twelve-month figure through Dec 2025 stood at $2.2 million (up 61.22% YoY), and the FY2025 full-year result was $2.1 million, up 54.49% from the prior year.
- Other Non-Current Assets improved to $2.2 million in Q4 2025, from $958625.2 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $5.0 million in Q2 2022 to a low of $710473.1 in Q1 2021.
- A 5-year average of $1.8 million and a median of $1.4 million in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets surged 390.53% in 2022 and slumped 56.98% in 2023, its largest moves.
- Tracing IMTX's Other Non-Current Assets over 5 years: stood at $727565.5 in 2021, then surged by 256.88% to $2.6 million in 2022, then decreased by 16.42% to $2.2 million in 2023, then slumped by 38.45% to $1.3 million in 2024, then surged by 61.22% to $2.2 million in 2025.
- Business Quant data shows IMTX's Other Non-Current Assets at $2.2 million in Q4 2025, $958625.2 in Q3 2025, and $1.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Immatics | 1.14 Bn | 1.14 Bn | - | 2.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.15 Mn |
| Sep 30, 2025 | 958,625.17 |
| Jun 30, 2025 | 1.13 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Dec 31, 2023 | 2.17 Mn |
| Sep 30, 2023 | 1.81 Mn |
| Jun 30, 2023 | 2.15 Mn |
| Mar 31, 2023 | 2.43 Mn |
| Dec 31, 2022 | 2.60 Mn |
| Sep 30, 2022 | 4.05 Mn |
| Jun 30, 2022 | 4.99 Mn |
| Mar 31, 2022 | 986,534.85 |
| Dec 31, 2021 | 727,565.52 |
| Sep 30, 2021 | 847,907.58 |
| Jun 30, 2021 | 1.02 Mn |
| Mar 31, 2021 | 710,473.07 |